UBS AG - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 102 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS AG ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2014$924,000
+1866.0%
88,959
+2967.6%
0.00%
Q2 2014$47,000
+34.3%
2,900
+31.8%
0.00%
Q1 2014$35,000
-83.6%
2,200
-87.2%
0.00%
Q4 2013$213,000
-42.0%
17,143
-48.8%
0.00%
Q3 2013$367,000
+47.4%
33,500
+8.8%
0.00%
Q2 2013$249,00030,8000.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders